SCLX Scilex Holding Company
Healthcare$6.41+4.83%ClosedMarket Cap: $54.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.17
P/S
1.53
EV/EBITDA
-0.43
DCF Value
$-47.25
FCF Yield
-12.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
55.0%
Operating Margin
-817.1%
Net Margin
-1239.4%
ROE
190.1%
ROA
-142.9%
ROIC
230.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $8.6M | 48.4% | $-32.2M | $-43.3M | $— | — |
| Q4 null | $4.8M | 12.3% | $-37.5M | $-33.1M | $— | — |
| FY null | $30.3M | 49.7% | $-272.3M | $-358.7M | $— | — |
| Q3 null | $10.6M | 68.5% | $-186.5M | $-257.2M | $— | — |
| Q2 null | $9.9M | 66.9% | $-20.5M | $-86.1M | $— | — |
| Q1 null | $5.0M | 72.3% | $-27.9M | $-26.1M | $— | — |
| Q4 null | $14.9M | 68.5% | $-28.4M | $-6.5M | $— | — |
| FY null | $56.6M | 70.5% | $-83.4M | $-72.8M | $— | — |
| Q3 null | $14.4M | 73.9% | $-19.9M | $-4.4M | $— | — |
| Q2 null | $16.4M | 73.2% | $-15.6M | $-37.6M | $— | — |
| Q1 null | $10.9M | 64.7% | $-19.5M | $-24.4M | $— | — |
| Q4 2023 | $13.5M | 58.7% | $-18.3M | $-21.4M | $-7.49 | — |